Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.230
+0.070 (2.22%)
Nov 21, 2024, 10:49 AM EST - Market open

Atea Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Revenue
---351.3748.63-
Upgrade
Revenue Growth (YoY)
---622.49%--
Upgrade
Cost of Revenue
78.2870.0962.39167.2138.0210.17
Upgrade
Gross Profit
-78.28-70.09-62.39184.1610.61-10.17
Upgrade
Selling, General & Admin
47.0249.9248.7145.7921.644.44
Upgrade
Operating Expenses
47.0249.9248.7145.7921.644.44
Upgrade
Operating Income
-125.3-120.01-111.1138.38-11.03-14.61
Upgrade
Interest & Investment Income
27.5429.2211.150.210.080.57
Upgrade
EBT Excluding Unusual Items
-97.76-90.79-99.95138.59-10.95-14.03
Upgrade
Other Unusual Items
-75.2-44.15-19.55---
Upgrade
Pretax Income
-172.96-134.94-119.5138.59-10.95-14.03
Upgrade
Income Tax Expense
1.051.02-3.5917.4--
Upgrade
Net Income
-174.01-135.96-115.91121.19-10.95-14.03
Upgrade
Net Income to Common
-174.01-135.96-115.91121.19-10.95-14.03
Upgrade
Shares Outstanding (Basic)
848383832210
Upgrade
Shares Outstanding (Diluted)
848383882210
Upgrade
Shares Change (YoY)
0.79%0.17%-5.67%308.70%113.98%0.52%
Upgrade
EPS (Basic)
-2.07-1.63-1.391.46-0.51-1.39
Upgrade
EPS (Diluted)
-2.07-1.63-1.391.37-0.51-1.39
Upgrade
Free Cash Flow
-126.94-85.4-122.93-87.01296.71-12.83
Upgrade
Free Cash Flow Per Share
-1.51-1.02-1.48-0.9913.74-1.27
Upgrade
Gross Margin
---52.41%21.82%-
Upgrade
Operating Margin
---39.38%-22.68%-
Upgrade
Profit Margin
---34.49%-22.51%-
Upgrade
Free Cash Flow Margin
----24.76%610.10%-
Upgrade
EBITDA
-124.88-119.59-110.84138.41-11.01-14.59
Upgrade
EBITDA Margin
---39.39%-22.64%-
Upgrade
D&A For EBITDA
0.420.420.260.030.020.02
Upgrade
EBIT
-125.3-120.01-111.1138.38-11.03-14.61
Upgrade
EBIT Margin
---39.38%-22.68%-
Upgrade
Effective Tax Rate
---12.55%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.